Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
PURPOSE: Radiotherapy for head and neck cancer causes acute and chronic xerostomia and acute mucositis. Amifositine and its active metabolite, WR-1065, accumulate with high concentrations in the salivary glands. This randomized trial evaluated whether amifostine could ameliorate these side effects without compromising the effectiveness of radiotherapy in these patients. PATIENTS AND METHODS: Patients with previously untreated head and neck squamous cell carcinoma were eligible. Primary end points included the incidence of grade ≥ 2 acute xerostomia, grade ≥ 3 acute mucositis, and grade ≥ 2 late xerostomia and were based on the worst toxicity reported. Amifostine was administered (200 mg/m 2 intravenous) daily 15 to 30 minutes before irradiation. Radiotherapy was given once daily (1.8 to 2.0 Gy) to doses of 50 to 70 Gy. Whole saliva production was quantitated preradiotherapy and regularly during follow-up. Patients evaluated their symptoms through a questionnaire during and after treatment. Local-regional control was the primary antitumor efficacy end point. RESULTS: Nausea, vomiting, hypotension, and allergic reactions were the most common side effects. Fifty-three percent of the patients receiving amifostine had at least one episode of nausea and/or vomiting, but it only occurred with 233 (5%) of 4,314 doses. Amifostine reduced grade ≥ 2 acute xerostomia from 78% to 51% (P < .0001) and chronic xerostomia grade ≥ 2 from 57% to 34% (P = .002). Median saliva production was greater with amifostine (0.26 g v 0.10 g, P = .04). Amifostine did not reduce mucositis. With and without amifostine, 2-year local-regional control, disease-free survival, and overall survival were 58% versus 63%, 53% versus 57%, and 71% versus 66%, respectively. CONCLUSION: Amifostine reduced acute and chronic xerostomia. Antitumor treatment efficacy was preserved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Brizel, D. M., Albers, M. E., Fisher, S. R., Scher, R. L., Richtsmeier, W. J., Hars, V., George, S. L., Huang, A. T., & Prosnitz, L. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382503 · Cited by 1,127
Self-citationMinimization: A new method of assigning patients to treatment and control groups
Taves, D. R. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974155443 · Cited by 891
Horiot, J. C., Le Fur, R., N'Guyen, T., Chenal, C., Schraub, S., Alfonsi, S., Gardani, G., Van Den Bogaert, W., Danczak, S., Bolla, M., et al. (1992) · Radiotherapy and Oncology · doi:10.1016/0167-8140(92)90242-m · Cited by 676
The randomization and stratification of patients to clinical trials
Zelen, M. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90015-0 · Cited by 613
Peters, L. J., Goepfert, H., Ang, K. K., Byers, R. M., Maor, M. H., Guillamondegui, O., Morrison, W. H., Weber, R. S., Garden, A. S., Frankenthaler, R. A., et al. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90167-t · Cited by 538
Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Panitch, H. S., Rose, J. W., Schiffer, R. B., et al. (1998) · Neurology · doi:10.1212/wnl.50.3.701 · Cited by 509
Horiot, J.-C., Bontemps, P., van den Bogaert, W., Le Fur, R., van den Weijngaert, D., Bolla, M., Bernier, J., Lusinchi, A., Stuschke, M., Lopez-Torrecilla, J., et al. (1997) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00079-0 · Cited by 506
Cited by
Forastiere, A., Koch, W., Trotti, A., & Sidransky, D. (2001) · New England Journal of Medicine · doi:10.1056/nejmra001375 · Cited by 1,250
Bentzen, S. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1950 · Cited by 1,096
Effects of radiation on normal tissue: consequences and mechanisms
Stone, H. B., Coleman, C. N., Anscher, M. S., & McBride, W. H. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01191-4 · Cited by 931
Rubenstein, E. B., Peterson, D. E., Schubert, M., Keefe, D., McGuire, D., Epstein, J., Elting, L. S., Fox, P. C., Cooksley, C., Sonis, S. T., et al. (2004) · Cancer · doi:10.1002/cncr.20163 · Cited by 820
Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer
Eisbruch, A., Kim, H. M., Terrell, J. E., Marsh, L. H., Dawson, L. A., & Ship, J. A. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01512-7 · Cited by 770
Interventions for treating oral mucositis for patients with cancer receiving treatment
Clarkson, J. E., Worthington, H. V., Furness, S., McCabe, M., Khalid, T., & Meyer, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001973.pub4 · Cited by 674
Eisbruch, A., Schwartz, M., Rasch, C., Vineberg, K., Damen, E., Van As, C. J., Marsh, R., Pameijer, F. A., & Balm, A. J. M. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.050 · Cited by 658
Wang, H., Mu, X., He, H., & Zhang, X.-D. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.11.003 · Cited by 572
The EGFR as a target for anticancer therapy—focus on cetuximab
Baselga, J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00233-7 · Cited by 563
Radiation-associated cardiovascular disease
Adams, M. J., Hardenbergh, P. H., Constine, L. S., & Lipshultz, S. E. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00227-x · Cited by 506
Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector
Kouvaris, J. R., Kouloulias, V. E., & Vlahos, L. J. (2007) · The Oncologist · doi:10.1634/theoncologist.12-6-738 · Cited by 456
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Wang, K., & Tepper, J. E. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21689 · Cited by 449
The concurrent chemoradiation paradigm—general principles
Seiwert, T. Y., Salama, J. K., & Vokes, E. E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0714 · Cited by 443
Prevention and Treatment of Dysphagia and Aspiration After Chemoradiation for Head and Neck Cancer
Rosenthal, D. I., Lewin, J. S., & Eisbruch, A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.0079 · Cited by 401
An update of the etiology and management of xerostomia
Porter, S. R., Scully, C., & Hegarty, A. M. (2004) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2003.07.010 · Cited by 378
Improving radiotherapy in cancer treatment: Promises and challenges
Chen, H. H. W., & Kuo, M. T. (2017) · Oncotarget · doi:10.18632/oncotarget.18409 · Cited by 372
MARKS, L., YU, X., VUJASKOVIC, Z., SMALLJR, W., FOLZ, R., & ANSCHER, M. (2003) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(03)00034-1 · Cited by 364
Radioprotection by plant products: present status and future prospects
Arora, R., Gupta, D., Chawla, R., Sagar, R., Sharma, A., Kumar, R., Prasad, J., Singh, S., Samanta, N., & Sharma, R. K. (2005) · Phytotherapy Research · doi:10.1002/ptr.1605 · Cited by 362
Oral complications of radiotherapy
Sciubba, J. J., & Goldenberg, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70580-0 · Cited by 358
Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol
Peh, H. Y., Tan, W. S. D., Liao, W., & Wong, W. S. F. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.12.003 · Cited by 351
Vissink, A., Mitchell, J. B., Baum, B. J., Limesand, K. H., Jensen, S. B., Fox, P. C., Elting, L. S., Langendijk, J. A., Coppes, R. P., & Reyland, M. E. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.06.052 · Cited by 342
Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
Sedighi, M., Zahedi Bialvaei, A., Hamblin, M. R., Ohadi, E., Asadi, A., Halajzadeh, M., Lohrasbi, V., Mohammadzadeh, N., Amiriani, T., Krutova, M., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2148 · Cited by 308
Advances in Radiotherapy and Implications for the Next Century: A Historical Perspective
Connell, P. P., & Hellman, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-07-6871 · Cited by 283
Role of antioxidants in cancer therapy
Fuchs-Tarlovsky, V. (2013) · Nutrition · doi:10.1016/j.nut.2012.02.014 · Cited by 282
Chambers, M. S., Garden, A. S., Kies, M. S., & Martin, J. W. (2004) · Head & Neck · doi:10.1002/hed.20045 · Cited by 277
Section, S. G. H., Jensen, S. B., Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO), Pedersen, A. M. L., Vissink, A., Andersen, E., Brown, C. G., Davies, A. N., Dutilh, J., et al. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0837-6 · Cited by 267
Blanco, A. I., Chao, K. S. C., El Naqa, I., Franklin, G. E., Zakarian, K., Vicic, M., & Deasy, J. O. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.12.076 · Cited by 266
Schuchter, L. M., Hensley, M. L., Meropol, N. J., & Winer, E. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.178 · Cited by 262
Interventions for preventing oral mucositis for patients with cancer receiving treatment
Worthington, H. V., Clarkson, J. E., Bryan, G., Furness, S., Glenny, A.-M., Littlewood, A., McCabe, M. G., Meyer, S., Khalid, T., & Riley, P. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000978.pub5 · Cited by 262
Sensitivity of Salivary Glands to Radiation: from Animal Models to Therapies
Grundmann, O., Mitchell, G. C., & Limesand, K. H. (2009) · Journal of Dental Research · doi:10.1177/0022034509343143 · Cited by 261
Radiation-induced liver disease: current understanding and future perspectives
Kim, J., & Jung, Y. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.85 · Cited by 260
History and development of radiation-protective agents
Weiss, J. F., & Landauer, M. R. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000902985144 · Cited by 258
Liauw, S. L., Connell, P. P., & Weichselbaum, R. R. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005148 · Cited by 257
Scully, C., Sonis, S., & Diz, P. (2006) · Oral Diseases · doi:10.1111/j.1601-0825.2006.01258.x · Cited by 253
Mittal, B. B., Pauloski, B. R., Haraf, D. J., Pelzer, H. J., Argiris, A., Vokes, E. E., Rademaker, A., & Logemann, J. A. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)01454-8 · Cited by 221
Future cancer research priorities in the USA: a Lancet Oncology Commission
Jaffee, E. M., Dang, C. V., Agus, D. B., Alexander, B. M., Anderson, K. C., Ashworth, A., Barker, A. D., Bastani, R., Bhatia, S., Bluestone, J. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30698-8 · Cited by 208
Parliament, M. B., Scrimger, R. A., Anderson, S. G., Kurien, E. C., Thompson, H. K., Field, G. C., & Hanson, J. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)01571-2 · Cited by 187
Mechanisms of inflammatory responses to radiation and normal tissues toxicity: clinical implications
Najafi, M., Motevaseli, E., Shirazi, A., Geraily, G., Rezaeyan, A., Norouzi, F., Rezapoor, S., & Abdollahi, H. (2018) · International Journal of Radiation Biology · doi:10.1080/09553002.2018.1440092 · Cited by 181
Proton therapy of cancer: Potential clinical advantages and cost-effectiveness
Lundkvist, J., Ekman, M., Ericsson, S. R., Jönsson, B., & Glimelius, B. (2005) · Acta Oncologica · doi:10.1080/02841860500341157 · Cited by 172
Komaki, R., Lee, J. S., Milas, L., Lee, H. K., Fossella, F. V., Herbst, R. S., Allen, P. K., Liao, Z., Stevens, C. W., Lu, C., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.10.005 · Cited by 172
Wasserman, T. H., Brizel, D. M., Henke, M., Monnier, A., Eschwege, F., Sauer, R., & Strnad, V. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.07.966 · Cited by 170
Self-citationFelice, P. A., Nelson, N. S., Page, E. E., Deshpande, S. S., Donneys, A., Rodriguez, J., & Buchman, S. R. (2014) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0000000000000543 · Cited by 14
Ecdysterone Attenuates the Development of Radiation-Induced Oral Mucositis in Rats at Early Stage
Yang, L., Friedemann, T., & Pan, J. (2021) · Radiation Research · doi:10.1667/rade-21-00042.1 · Cited by 5
Metadata
- Authors
- Brizel, D. M., Wasserman, T. H., Henke, M., Strnad, V., Rudat, V., Monnier, A., Eschwege, F., Zhang, J., Russell, L., Oster, W., & Sauer, R.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-10-19
- Volume
- 18
- Issue
- 19
- Pages
- 3339-3345
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2157885764
- Cited by
- 828
- References
- 25
- FWCI
- 40.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.